Whole genome amplification of plasma-circulating DNA enables expanded screening for allelic imbalance in plasma

Journal of Molecular Diagnostics

Volumn 8, Issue 1, 2006, Pages 22-30

  Li, Jin ^a   Harris, Lyndsay ^a   Mamon, Harvey ^a   Kulke, Matthew H ^a   Liu, Wei Hua ^a   Zhu, Penny ^a   Makrigiorgos, G Mike ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA POLYMERASE; DOUBLE STRANDED DNA; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; PRIMER DNA; TUMOR MARKER;

APOPTOSIS; ARTICLE; BODY FLUID; BREAST CANCER; CANCER DIAGNOSIS; CANCER PATIENT; CELL DEATH; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DIAGNOSTIC KIT; DNA POLYMORPHISM; DNA PURIFICATION; FEMALE; GENE AMPLIFICATION; GENE DISRUPTION; GENETIC PROCEDURES; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; PLASMA; RELIABILITY; SENSITIVITY ANALYSIS; STORAGE;

EID: 32944463318     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.2353/jmoldx.2006.050074     Document Type: Article

References (49)

1. Leon SA, Shapiro B, Sklaroff DM, Yaros MJ: Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 1977, 37:646-650
2. Jahr S, Hentze H, Englisch S, Hardt D, Fackelmayer FO, Hesch RD, Knippers R: DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res 2001, 61:1659-1665
3. Anker P, Mulcahy H, Chen XQ, Stroun M: Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients. Cancer Metastasis Rev 1999, 18:65-73
4. Mulcahy HE, Lyautey J, Lederrey C, Chen XQ, Lefort F, Vasioukhin V, Anker P, Alstead EM, Farthing MJ, Stroun M: Plasma DNA K-ras mutations in patients with gastrointestinal malignancies. Ann NY Acad Sci 2000, 906:25-28
5. Wang BG, Huang HY, Chen YC, Bristow RE, Kassauei K, Cheng CC, Roden R, Sokoll LJ, Chan DW, Shih le M: Increased plasma DNA integrity in cancer patients. Cancer Res 2003, 63:3966-3968
6. Sidransky D: Emerging molecular markers of cancer. Nat Rev Cancer 2002, 2:210-219
7. Chang HW, Lee SM, Goodman SN, Singer G, Cho SK, Sokoll LJ, Montz FJ, Roden R, Zhang Z, Chan DW, Kurman RJ, Shih le M: Assessment of plasma DNA levels, allelic imbalance, and CA 125 as diagnostic tests for cancer. J Natl Cancer Inst 2002, 94:1697-1703
8. Chen XQ, Stroun M, Magnenat JL, Nicod LP, Kurt AM, Lyautey J, Lederrey C, Anker P: Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat Med 1996, 2:1033-1035
9. Lo YM, Chan LY, Lo KW, Leung SF, Zhang J, Chan AT, Lee JC, Hjelm NM, Johnson PJ, Huang DP: Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Cancer Res 1999, 59:1188-1191
10. Silva JM, Gonzalez R, Dominguez G, Garcia JM, Espana P, Bonilla F: TP53 gene mutations in plasma DNA of cancer patients. Genes Chromosom Cancer 1999, 24:160-161
11. Shao ZM, Wu J, Shen ZZ, Nguyen M: p53 mutation in plasma DNA and its prognostic value in breast cancer patients. Clin Cancer Res 2001, 7:2222-2227
12. Silva JM, Dominguez G, Villanueva MJ, Gonzalez R, Garcia JM, Corbacho C, Provencio M, Espana P, Bonilla F: Aberrant DNA methylation of the p16INK4a gene in plasma DNA of breast cancer patients. Br J Cancer 1999, 80:1262-1264
13. Silva JM, Dominguez G, Garcia JM, Gonzalez R, Villanueva MJ, Navarro F, Provencio M, San Martin S, Espana P, Bonilla F: Presence of tumor DNA in plasma of breast cancer patients: clinicopathological correlations. Cancer Res 1999, 59:3251-3256
14. Shao ZM, Nguyen M: Tumor-specific DNA in plasma of breast cancer patients. Anticancer Drugs 2002, 13:353-357
15. Kopreski MS, Benko FA, Gocke CD: Circulating RNA as a tumor marker: detection of 5T4 mRNA in breast and lung cancer patient serum. Ann NY Acad Sci 2001, 945:172-178
16. Shaw JA, Smith BM, Walsh T, Johnson S, Primrose L, Slade MJ, Walker RA, Coombes RC: Microsatellite alterations in plasma DNA of primary breast cancer patients. Clin Cancer Res 2000, 6:1119-1124
17. Hu XC, Wong IH, Chow LW: Tumor-derived aberrant methylation in plasma of invasive ductal breast cancer patients: clinical implications. Oncol Rep 2003, 10:1811-1815
18. Kuroi K, Tanaka C, Toi M: Plasma nucleosome levels in node-negative breast cancer patients. Breast Cancer 1999, 6:361-364
19. Silva JM, Silva J, Sanchez A, Garcia JM, Dominguez G, Provencio M, Sanfrutos L, Jareno E, Colas A, Espana P, Bonilla F: Tumor DNA in plasma at diagnosis of breast cancer patients is a valuable predictor of disease-free survival. Clin Cancer Res 2002, 8:3761-3766
20. Silva JM, Garcia JM, Dominguez G, Silva J, Miralles C, Cantos B, Coca S, Provencio M, Espana P, Bonilla F: Persistence of tumor DNA in plasma of breast cancer patients after mastectomy. Ann Surg Oncol 2002, 9:71-76
21. Wagner PD, Verma M, Srivastava S: Challenges for biomarkers in cancer detection. Ann NY Acad Sci 2004, 1022:9-16
22. Wang ZC, Lin M, Wei L-J, Li C, Miron A, Lodeiro G, Harris L, Ramaswamy S, Tanenbaum DM, Meyerson M, Iglehart JD, Richardson A: Loss of heterozygosity and its correlation with expression profiles in subclasses of invasive breast cancers. Cancer Res 2004, 64:64-71
23. Osborne RJ, Hamshere MG: A genome-wide map showing common regions of loss of heterozygosity/allelic imbalance in breast cancer. Cancer Res 2000, 60:3706-3712
24. Miller BJ, Wang D, Krahe R, Wright FA: Pooled analysis of loss of heterozygosity in breast cancer: a genome scan provides comparative evidence for multiple tumor suppressors and identifies novel candidate regions. Am J Hum Genet 2003, 73:748-767
25. Widschwendter M, Jones PA: DNA methylation and breast carcinogenesis. Oncogene 2002, 21:5462-5482
26. Szyf M, Pakneshan P, Rabbani SA: DNA methylation and breast cancer. Biochem Pharmacol 2004, 68:1187-1197
27. Garcia JM, Silva JM, Dominguez G, Silva J, Bonilla F: Heterogeneous tumor clones as an explanation of discordance between plasma DNA and tumor DNA alterations. Genes Chromosom Cancer 2001, 31:300-301
28. Hibi K, Robinson CR, Booker S, Wu L, Hamilton SR, Sidransky D, Jen J: Molecular detection of genetic alterations in the serum of colorectal cancer patients. Cancer Res 1998, 58:1405-1407
29. Kolble K, Ullrich OM, Pidde H, Barthel B, Diermann J, Rudolph B, Dietel M, Schlag PM, Scherneck S: Microsatellite alterations in serum DNA of patients with colorectal cancer. Lab Invest 1999, 79:1145-1150
30. Sieben NL, ter Haar NT, Cornelisse CJ, Fleuren GJ, Cleton-Jansen AM: PCR artifacts in LOH and MSI analysis of microdissected tumor cells. Hum Pathol 2000, 31:1414-1419
31. Coulet F, Blons H, Cabelguenne A, Lecomte T, Lacourreye O, Brasnu D, Beaune P, Zucman J, Laurent-Puig P: Detection of plasma tumor DNA in head and neck squamous cell carcinoma by microsatellite typing and p53 mutation analysis. Cancer Res 2000, 60:707-711
32. Silva JM, Bonilla F: Detection of plasma tumor DNA in head and neck squamous cell carcinoma by microsatellite typing and p53 mutation analysis. Cancer Res 2001, 61:8595-8596
33. Chen X, Bonnefoi H, Diebold-Berger S, Lyautey J, Lederrey C, Faltin-Traub E, Stroun M, Anker P: Detecting tumor-related alterations in plasma or serum DNA of patients diagnosed with breast cancer. Clin Cancer Res 1999, 5:2297-2303
34. Mayall F, Fairweather S, Wilkins R, Chang B, Nicholls R: Microsatellite abnormalities in plasma of patients with breast carcinoma: concordance with the primary tumour. J Clin Pathol 1999, 52:363-366
35. Klein CA, Schmidt-Kittler O, Schardt JA, Pantel K, Speicher MR, Riethmuller G: Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells. Proc Natl Acad Sci USA 1999, 96:4494-4499
36. Makrigiorgos GM, Chakrabarti S, Zhang Y, Kaur M, Price BD: A PCR-based amplification method retaining the quantitative difference between two complex genomes. Nat Biotechnol 2002, 20:936-939
37. Wang G, Brennan C, Rook M, Wolfe JL, Leo C, Chin L, Pan H, Liu WH, Price B, Makrigiorgos GM: Balanced-PCR amplification allows unbiased identification of genomic copy changes in minute cell and tissue samples. Nucleic Acids Res 2004, 32:e76
38. Lucito R, Nakimura M, West JA, Han Y, Chin K, Jensen K, McCombie R, Gray JW, Wigler M: Genetic analysis using genomic representations. Proc Natl Acad Sci USA 1998, 95:4487-4492
39. Hosono S, Faruqi AF, Dean FB, Du Y, Sun Z, Wu X, Du J, Kingsmore SF, Egholm M, Lasken RS: Unbiased whole-genome amplification directly from clinical samples. Genome Res 2003, 13:954-964
40. Dean FB, Hosono S, Fang L, Wu X, Farugi AF, Bray-Ward P, Sun Z, Zong Q, Du Y, Du J, Driscoll M, Song W, Kingsmore SF, Egholm M, Lasken RS: Comprehensive human genome amplification using multiple displacement amplification. Proc Natl Acad Sci USA 2002, 99:5261-5266
41. Lage JM, Leamon JH, Pejovic T, Hamann S, Lacey M, Dillon D, Segraves R, Vossbrinck B, Gonzalez A, Pinkel D, Albertson DG, Costa J, Lizardi PM: Whole genome analysis of genetic alterations in small DNA samples using hyperbranched strand displacement amplification and array-CGH. Genome Res 2003, 13:294-307
42. Wang G, Maher E, Brennan C, Chin L, Leo C, Kaur M, Zhu P, Rook M, Wolfe JL, Makrigiorgos GM: DNA amplification method tolerant to sample degradation. Genome Res 2004, 14:2357-2366
43. Heid C, Stevens J, Livak K, Williams P: Real time quantitative PCR. Genome Methods: Genome Research. Cold Spring Harbor, Cold Spring Harbor Laboratory Press, 1996, pp 986-994
44. Kleymenova E, Walker CL: Determination of loss of heterozygosity in frozen and paraffin embedded tumors by denaturating high-performance liquid chromatography (DHPLC). J Biochem Biophys Methods 2001, 47:83-90
45. Boettger MB, Sergi C, Meyer P: BRCA1/2 mutation screening and LOH analysis of lung adenocarcinoma tissue in a multiple-cancer patient with a strong family history of breast cancer. J Carcinog 2003, 2:5
46. Liu W, Smith DI, Rechtzigel KJ, Thibodeau SN, James CD: Denaturing high performance liquid chromatography (DHPLC) used in the detection of germline and somatic mutations. Nucleic Acids Res 1998, 26:1396-1400
47. Rook MS, Delach SM, Deyneko G, Worlock A, Wolfe JL: Whole genome amplification of DNA from laser capture-microdissected tissue for high-throughput single nucleotide polymorphism and short tandem repeat genotyping. Am J Pathol 2004, 164:23-33
48. Sorenson GD: A review of studies on the detection of mutated KRAS2 sequences as tumor markers in plasma/serum of patients with gastrointestinal cancer. Ann NY Acad Sci 2000, 906:13-16
49. Wang Q, Larson PS, Schlechter BL, Zahid N, Finnemore E, de las Morenas A, Blanchard RA, Rosenberg CL: Loss of heterozygosity in serial plasma DNA samples during follow-up of women with breast cancer. Int J Cancer 2003, 106:923-929